Good news is on the way about hoe EMRLIS could help treat your NSCLC
Keep an eye on your inbox for detailed information about how this breakthrough treatment might be the right one for you.
NSCLC=non-small cell lung cancer.
USE
What is EMRELIS?
EMRELIS™ is a prescription medicine used to treat adults with non-squamous non-small cell lung cancer (NSCLC):
- that has spread to areas near the lungs (locally advanced) or to other parts of the body (metastatic), and
- whose tumors have high c-Met protein overexpression, and
- who have received a prior treatment.
Your healthcare provider will perform a test to make sure EMRELIS is right for you.
It is not known if EMRELIS is safe and effective in children.
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about EMRELIS?
EMRELIS can cause serious side effects, including:
- Nerve problems in your hands or feet (peripheral neuropathy). Nerve problems are common during treatment with EMRELIS and can also be severe. Tell your healthcare provider if you develop any new or worsening signs or symptoms of nerve problems, including:
- numbness
- tingling
- burning sensation
- pain or discomfort
- muscle weakness
- difficulty walking
- Lung problems. EMRELIS can cause lung problems that may be severe, life-threatening, or that may lead to death. Tell your healthcare provider right away if you develop new or worsening lung symptoms, including:
- cough
- trouble breathing or shortness of breath
- fever
- wheezing
- Eye problems. Your healthcare provider may send you to an eye care professional to check your eyes if you develop eye problems. Tell your healthcare provider right away if you develop any new or worsening eye problems or vision changes, including:
- blurred vision
- dry eyes
- sensitivity to light
- eye pain or swelling
- eye redness
- Infusion-related reactions. EMRELIS can cause infusion reactions that can be severe or life-threatening. Tell your healthcare provider right away if you develop any signs and symptoms of infusion reactions, including:
- itching or rash
- shortness of breath or wheezing
- flushing
- chest discomfort
- fever
- back pain
- chills
- headache
- nausea or vomiting
- feel like passing out
Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with EMRELIS and may provide treatment for your side effects. Your healthcare provider may also need to change your dose, temporarily stop, or completely stop treatment with EMRELIS if you have severe side effects.
Before receiving EMRELIS, tell your healthcare provider about all of your medical conditions, including if you:
- have a history of nerve problems
- have lung or breathing problems other than your lung cancer
- have eye problems
- have liver problems
- are pregnant or plan to become pregnant. EMRELIS can harm your unborn baby.
- Females who are able to become pregnant:
- Your healthcare provider should do a pregnancy test before you start treatment with EMRELIS.
- You should use effective birth control (contraception) during treatment and for 2 months after your last dose of EMRELIS.
- Tell your healthcare provider if you become pregnant or think that you may be pregnant during treatment with EMRELIS.
- Males with female partners who are able to become pregnant:
- You should use an effective birth control during treatment and for 4 months after taking the last dose of EMRELIS.
- Females who are able to become pregnant:
- are breastfeeding or plan to breastfeed. It is not known if EMRELIS passes into your breast milk. Do not breastfeed during treatment with EMRELIS and for 1 month after the last dose.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking certain medicines with EMRELIS may increase your risk of side effects.
How will I receive EMRELIS?
- Your healthcare provider will give you EMRELIS into your vein through an intravenous (IV) line over 30 minutes.
- EMRELIS is given 1 time every 2 weeks.
- Your healthcare provider will decide how many infusions of EMRELIS you will receive.
What are the possible side effects of EMRELIS?
EMRELIS can cause serious side effects. See “What is the most important information I should know about EMRELIS?”
The most common side effects of EMRELIS include:
- feeling tired
- decreased appetite
- swelling in the feet, ankles, legs, or hands
The most common severe abnormal laboratory tests results of EMRELIS include:
- decreased white blood cell counts
- increased blood sugar levels
- increased blood liver enzyme levels
- decreased blood phosphorus levels
- decreased blood sodium levels
- decreased red blood cell counts
- decreased blood calcium levels
EMRELIS may cause fertility problems in females and males, which may affect the ability to have children. Talk to your healthcare provider if you have concerns about fertility.
These are not all the possible side effects of EMRELIS.
Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.
US-TEL-250027
Please see full Prescribing Information, including Medication Guide.